ERCC1 and non-small cell lung carcinoma: Clinical studies have revealed that ERCC1 expression levels serve as a reliable predictor of treatment outcomes in non-small cell lung cancer patients, with high ERCC1 expression correlating with a 50% reduction in progression-free survival [11].